InMode Ltd. is a provider of medical technologies. It develops, manufactures and markets devices harnessing novel radio-frequency technology. The company serves plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode Ltd. is based in Yokneam, Israel.
Revenue (Most Recent Fiscal Year) | $492.05M |
Net Income (Most Recent Fiscal Year) | $197.92M |
PE Ratio (Current Year Earnings Estimate) | 10.47 |
PE Ratio (Trailing 12 Months) | 8.42 |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 3.40 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.94 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 8.52 |
Pre-Tax Margin (Trailing 12 Months) | 44.30% |
Net Margin (Trailing 12 Months) | 38.84% |
Return on Equity (Trailing 12 Months) | 26.15% |
Return on Assets (Trailing 12 Months) | 23.83% |
Current Ratio (Most Recent Fiscal Quarter) | 13.45 |
Quick Ratio (Most Recent Fiscal Quarter) | 12.66 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
Inventory Turnover (Trailing 12 Months) | 2.05 |
Book Value per Share (Most Recent Fiscal Quarter) | $9.71 |
Earnings per Share (Most Recent Fiscal Quarter) | $0.41 |
Earnings per Share (Most Recent Fiscal Year) | $2.30 |
Diluted Earnings per Share (Trailing 12 Months) | $2.11 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Medical Devices |
Common Shares Outstanding | 83.98M |
Free Float | 78.17M |
Market Capitalization | $1.58B |
Average Volume (Last 20 Days) | 1.28M |
Beta (Past 60 Months) | 2.20 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 6.92% |
Percentage Held By Institutions (Latest 13F Reports) | 68.04% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |